MedPath

0-phobia: Towards a virtual cure for specific phobias

Completed
Conditions
acrophobia and fear of heights
10002861
Registration Number
NL-OMON45728
Lead Sponsor
Vrije Universiteit
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
154
Inclusion Criteria

-scoring above 45.45 on the AQ-Anxiety
-are between 18-64 years old
-have access to a smart phone (Android) and internet
-willing to participate in the research study and providing informed consent
-willing to fill in questionnaires (4 times)

Exclusion Criteria

A potential subject who meets any of the following criteria will be excluded from participation in this study:
-present with symptoms of severe depression or suicidality respectively as measured with the PHQ-9; total score > 19 or a score 3 on the suicidal ideation question of the WSQ (Donker et al. 2009)
-have insufficient knowledge of the Dutch language
-are under current treatment for specific phobia or psychotropic medication (unless on stable dosage for the previous 3 months and no changes planned during the study period)

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>The main parameter will be the Acrophobia Questionnaire (AQ, Cohen; 1977)<br /><br>subscale anxiety, a 20-item self-report questionnaire to measure fear of<br /><br>heights (fear and avoidance). The 20-item anxiety subscale has a 7-point Likert<br /><br>scale (*not anxious* to *extremely anxious*), total score 0-120. The<br /><br>questionnaire is widely-used and has good psychometric properties (Cohen,<br /><br>1977). This measure will be given at baseline, post-test and follow-up and<br /><br>takes 5 minutes to complete. To be considered for inclusion, individuals have<br /><br>to score at least a 45.45 on the AQ-Anxiety (one standard deviation below the<br /><br>mean of a previous acrophobic sample; Cohen, 1972; Steinman and Teachman, 2011)</p><br>
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath